Author:
Zwiauer K.F.M.,Bröker M.,Banzhoff A.
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference13 articles.
1. Zwiauer KFM, Bröker M, Banzhoff A (2014) Der neue Mehrfachkomponentenimpfstoff 4CMenB zum Schutz vor Erkrankungen durch Meningokokken der Serogruppe B. Teil 1: Klinische Daten zur Immunogenität. Pädiatr Pädol 49
2. Gossger N, Snape MD, Yu LM et al (2012) Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA 307:573–582
3. Vesikari T, Esposito S, Prymula R et al (2013) Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet 381:825–835
4. Prymula R, Esposito S, Zuccotti GV et al (2014) A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine. (I) Effects of prophylactic paracetamol on immunogenicity and reactogenicity of routine infant vaccines and 4CMenB. Hum Vaccin Immunother 10:1992–2003
5. Dull P, Banzhoff A, Toneatto D (2013) Concomitant administration of meningococcal serogroup B vaccine with routine infant vaccines including rotavirus vaccines. 8th World Congress of the World Society for Pedriatric Infectious Diseases. Cape Town, Südafrika, 19.–22. November, 2013, Poster